advertisement
Survey of Ophthalmology 6
Showing records 1 to 6 | Display all abstracts in Survey of Ophthalmology5635 Human corneal thickness and its impact on intraocular pressure measures: a review and meta-analysis approach
Doughty MJ; Zaman ML
Survey of Ophthalmology 2000; 44: 367-408
5821 Increased optic nerve head blood flow after one week of twice daily topical brinzolamide treatment in Dutch-belted rabbits
Barnes GE; Li B; Dean T; Chandler ML
Survey of Ophthalmology 2000; 44(Suppl 2):S131-S140
5825 The efficacy and safety of brinzolamide 1% ophthalmic suspension (Azopt) as a primary therapy in patients with open-angle glaucoma or ocular hypertension: Brinzolamide Primary Therapy Study Group
Sall K; Assil KK; Beehler CC; Cacioppo L; Caine R; DiGaetano M; Friedlaender M; Friedland B; Greenidge K; Gross RL
Survey of Ophthalmology 2000; 44(Suppl 2):S155-S162
5826 Adjunctive therapy with brinzolamide 1% ophthalmic suspension (Azopt) in patients with open-angle glaucoma or ocular hypertension maintained on timolol therapy
Shin DD; Atlas W; Brotherman D; Caine R; Craven R; Gottlieb L; Kolodner H; Kraff C; Kranemann C; Krupin T
Survey of Ophthalmology 2000; 44(Suppl 2):S163-S168
5827 Dose-response evaluation of the ocular hypotensive effect of brinzolamide ophthalmic suspension (Azopt): Brinzolamide Dose-Response Study Group
Silver LH
Survey of Ophthalmology 2000; 44(Suppl 2):S147-S153
5828 Ocular comfort of brinzolamide 1.0% ophthalmic suspension compared with dorzolamide 2.0% ophthalmic solution: results from two multicenter comfort studies: Brinzolamide Comfort Study Group
Silver LH
Survey of Ophthalmology 2000; 44(Suppl 2):S141-S145
